Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SELB

Selecta Biosciences (SELB) Stock Price, News & Analysis

Selecta Biosciences logo

About Selecta Biosciences Stock (NASDAQ:SELB)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.88
$1.26
52-Week Range
N/A
Volume
2.77 million shs
Average Volume
979,585 shs
Market Capitalization
$136.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SELB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Selecta Biosciences and its competitors with MarketBeat's FREE daily newsletter.

SELB Stock News Headlines

Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
Cartesian Therapeutics Inc (RNAC)
See More Headlines

SELB Stock Analysis - Frequently Asked Questions

Selecta Biosciences, Inc. (NASDAQ:SELB) posted its quarterly earnings results on Thursday, August, 17th. The company reported ($0.07) EPS for the quarter, beating analysts' consensus estimates of ($0.12) by $0.05. The business had revenue of $5.25 million for the quarter, compared to analysts' expectations of $9.90 million. Selecta Biosciences had a negative trailing twelve-month return on equity of 44.13% and a negative net margin of 72.04%.
Read the conference call transcript
.

Selecta Biosciences (SELB) raised $64 million in an initial public offering on Wednesday, June 22nd 2016. The company issued 4,300,000 shares at $14.00-$16.00 per share. UBS Investment Bank and Stifel acted as the underwriters for the IPO and Canaccord Genuity and Needham & Company were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Selecta Biosciences investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), GE Aerospace (GE), Pfizer (PFE), CrowdStrike (CRWD).

Company Calendar

Last Earnings
8/17/2023
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:SELB
CIK
1453687
Employees
64
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.22)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$35.38 million
Net Margins
-72.04%
Pretax Margin
-73.23%
Return on Equity
-44.13%
Return on Assets
-22.00%

Debt

Debt-to-Equity Ratio
0.21
Current Ratio
4.18
Quick Ratio
4.18

Sales & Book Value

Annual Sales
$110.78 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
9.91
Book Value
$0.61 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
155,200,000
Free Float
106,780,000
Market Cap
$136.76 million
Optionable
Optionable
Beta
0.84

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:SELB) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners